Latest filing published 24 Jun 2021 for Cyteir Therapeutics, Inc., €4.2M.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Droia Invest II SCSp: trading record in brief
All filings by Droia Invest II SCSp on record concern Cyteir Therapeutics, Inc. Activity is concentrated on a single trading day, 22 June 2021, with 2 filings.
Purchases make up the whole of the open-market record (1 purchase, €4.2M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The record was last updated on 24 June 2021 with an open-market purchase (€4.2M) in Cyteir Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Droia Invest II SCSp
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 277,777 shares@ US$18.00100.0% of flowCommon StockSEC:0000899243-21-025828:1Canonical exit: 20 Sept 2021 (T+90)
- 3,259,026 sharesCommon StockSEC:0000899243-21-025828:0
2 of 1 declaration